Role of PSMA-ligands imaging in Renal Cell Carcinoma management: current status and future perspectives
Luca Urso(University of Ferrara), Mirco Bartolomei(University of Ferrara), Massimo Castellani(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Luigia Florimonte(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Carmelo Ippolito(University of Ferrara), Angelo Castello(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Licia Uccelli(University of Ferrara), Antonio Frassoldati(Italian Oncology Group of Clinical Research), Federica Lancia(University of Ferrara), Giovanni Christian Rocca(University of Ferrara), Stefano Panareo(Arcispedale Sant'Anna), Corrado Cittanti(University of Ferrara)
Cited by 52
Related Papers
Preoperative Chemotherapy Plus Trastuzumab, Lapatinib, or Both in Human Epidermal Growth Factor Receptor 2–Positive Operable Breast Cancer: Results of the Randomized Phase II CHER-LOB Study
|Journal of Clinical Oncology|2012|368
Zoledronic acid (zoledronate) for postmenopausal women with early breast cancer receiving adjuvant letrozole (ZO-FAST study): final 60-month results
|Annals of Oncology|2012|339
Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy
|Cancer Research|2010|244
Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab
|Clinical Cancer Research|2019|240